Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance
Go back to Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance| (NASDAQ: COLL) | Delayed: 21.82 -0.41 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.23 | 52 Week High | $30.58 | |||
| Open | $22.14 | 52 Week Low | $8.24 | |||
| Day High | $22.33 | P/E | N/A | |||
| Day Low | $21.82 | EPS | $0.00 | |||
| Volume | 811,564 | |||||

